-
Summit Therapeutics (NASDAQ:SMMT) Given Buy Rating at HC Wainwright
Source: Buzz FX / 04 Oct 2024 07:41:11 America/Chicago
Summit Therapeutics (NASDAQ:SMMT) Given Buy Rating at HC Wainwright Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Summit Therapeutics ( NASDAQ:SMMT - Get Free Report ) 's stock had its "buy" rating reissued by resear
Read more...